Myosure Tissue Removal Device
Payments companies reported to CMS as associated with Myosure Tissue Removal Device. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Myosure Tissue Removal Device, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Myosure Tissue Removal Device
These are the largest totals companies reported as associated with Myosure Tissue Removal Device. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michelle Louie | Scottsdale, AZ | Gynecology | $20,726.68 |
| Charles Miller | Naperville, IL | Obstetrics & Gynecology | $14,706.32 |
| Holly Miller | Naples, FL | Obstetrics & Gynecology | $13,845.16 |
| Michael Scheiber | Cincinnati, OH | Reproductive Endocrinology | $10,989.00 |
| Denise Sweeney | Granite Bay, CA | Obstetrics & Gynecology | $8,985.85 |
| Otis Stitt | Silver Spring, MD | Obstetrics & Gynecology | $8,744.31 |
| Taraneh Shirazian | New York, NY | Obstetrics & Gynecology | $8,742.96 |
| Erica Robinson | Worcester, MA | Obstetrics & Gynecology | $7,848.28 |
| Navkaran Singh | Las Vegas, NV | Obstetrics & Gynecology | $7,425.63 |
| Warren Huber | Providence, RI | Obstetrics & Gynecology | $6,688.63 |
Prescribed Myosure Tissue Removal Device?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.